This section of the site requires the Flash player.
Get the latest flash player.

Boucher & Muir Pty Ltd (BNM) was incorporated in 1957 by Sydney Frish and Otto Ekstein. Through its humble beginnings, BNM has developed into a main stream pharmaceutical company serving the domestic and internal markets including NZ and Pacific Island countries. Using its long trading history and pharmaceutical market knowledge, combined with its young and highly energetic employees, BNM has carefully carved its niche in the crowded pharmaceuticals market. 

In 2015 BNM was acquired by AMCo, after ten years of BNM being one of AMCo's main distributors for medicines in the region. Later that same year, BNM and AMCo came under the ownership of the Canadian Concordia Healthcare Corp (TSX, NASDAQ) through its acquisition of AMCo. BNM continues to espouse strong family values in its daily operations. These values form the backbone of the company's mission to protect the health of families through the provision of quality medicines and medical products.

Latest News

  • AMCo acquires Australian company Boucher & Muir read more

  • Paracetamol BNM solution for injection launches in AU inread more